Скачать или смотреть Endocrinology Update by LucidQuest Episode 10

Top Advances in Metabolic Health: New Treatments, Global T2D Trends, Real-World Data & Innovation in Endocrinology.

In this episode, we cover the most important developments shaping the future of metabolic health, including new treatments, real-world data insights, global trends, and clinical innovations.

🔬 Highlights this week include:

🧪 CuraTeQ’s denosumab biosimilar shows bioequivalence in Phase 1 trials

🌍 Global CPR launched by IDF for Type 2 diabetes care

💊 Oral semaglutide cuts major cardiovascular risk by 14 percent overall—and 27 percent in Asian patients

⏳ Real-world tirzepatide use slower than expected, impacting outcomes

🧬 New sex-based bone regeneration insights may shape personalized therapies

🫘 Glucosamine linked to lower kidney risk in people with T2D

📈 Poland reports Europe’s sharpest spike in pediatric Type 1 diabetes

🔬 Protein discovery may reduce or eliminate insulin use

🧠 Cognitive and glycemic improvements seen with Cdk5 inhibitor in preclinical trials

📲 Dexcom G7 CGM cleared by FDA for extended 15-day use with improved accuracy


Whether you're a clinician, researcher, or healthcare strategist, this update delivers actionable insights into the evolving endocrinology landscape.

📢 Stay Ahead in Endocrinology Research!
✅ Like, share, and subscribe for weekly updates on diabetes, obesity, and metabolic health
✅ Visit www.lqventures.com for expert healthcare insights and consulting services
✅ Contact LucidQuest at [email protected] for strategic guidance on endocrinology innovations and clinical research
🔔 Turn on notifications so you never miss an update!

#Endocrinology #DiabetesCare #ClinicalResearch #T2D #T1D #CardiometabolicHealth #PharmaNews #LucidQuest #MedicalInnovation #GlucoseMonitoring #DigitalHealth